Showing results (1071-1080 of 1,183) with videos related to
Sort By:
Pageof 119
Physical Review Letters|February 21, 2006
Structure of 12Be: intruder d-wave strength at N=8S D Pain, W N Catford, N A Orr, et al.Oncogene|January 24, 2012
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastomaE L Carpenter, E A Haglund, E M Mace, et al.Journal of the American Chemical Society|December 16, 2025
Unravelling the Stability Stressors of Atomically Dispersed Fe-N-C Oxygen Reduction CatalystsXiaohong Xie, Boyang Li, Pan Xu, et al.Science Advances|May 14, 2025
Detection of visible-wavelength aurora on MarsElise W Knutsen, Timothy H McConnochie, Mark Lemmon, et al.Science Translational Medicine|April 12, 2019
Cbp-dependent histone acetylation mediates axon regeneration induced by environmental enrichment in rodent spinal cord injury modelsThomas H Hutson, Claudia Kathe, Ilaria Palmisano, et al.Evolution; International Journal of Organic Evolution|January 19, 2018
Phylogenetic patterns of trait and trait plasticity evolution: Insights from amphibian embryosRick A Relyea, Patrick R Stephens, Lisa N Barrow, et al.Cancer Research|March 21, 2020
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> MutationsJacqueline H Starrett, Alexis A Guernet, Maria Emanuela Cuomo, et al.Science (New York, N.Y.)|December 31, 1997
Results from the Mars Pathfinder cameraP H Smith, J F Bell, N T Bridges, et al.Cancer Research|January 29, 2021
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J Wolpaw, Richard Bayliss, Gabriele Büchel, et al.Molecular Cancer Therapeutics|November 15, 2018
MTORC1/2 Inhibition as a Therapeutic Strategy for <i>PIK3CA</i> Mutant CancersStephanie L Fricke, Susan N Payne, Peter F Favreau, et al.Pageof 119